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Abstract 
Background: Human amnion mesenchymal cells (hAMCs), isolated from the amniotic membrane of human pla-
centa, are a unique population of mesenchymal stem cells. Recent studies demonstrated that hAMCs could inhibit 
the activities and functions of several immune cells. However, their effect on inflammatory macrophages is largely 
unknown. This study investigated the effect of hAMCs on expression of inflammatory cytokines and mitogen-acti-
vated protein kinases (MAPKs)/NF-κB pathway in human THP-1 macrophages induced by lipopolysaccharide (LPS).
Results: The levels of TNF-α and IL-1β secreted by LPS- stimulated THP-1 cells were increased significantly compared 
with those in the control group. After co-culture with different numbers of hAMCs, the levels of TNF-α and IL-1β in 
LPS-stimulated THP-1 cells were significantly reduced compared with the LPS group. The mRNA expression of TNF-α 
and IL-1β were also markedly inhibited. Moreover, treating LPS-stimulated THP-1 cells with hAMCs supernatants could 
also suppress TNF-α and IL-1β production in THP-1 cells. Important signaling pathways involved in the production 
of TNF-α and IL-1β were affected by hAMCs co-culture: hAMCs remarkably suppressed NF-κB activation and down-
regulated the phosphorylation of ERK and JNK in LPS- stimulated THP-1 cells.
Conclusions: Human amnion mesenchymal cells inhibited the production of TNF-α and IL-1β secreted by LPS-stimu-
lated THP-1 cells, partly through the suppression of NF-κB activation and ERK and JNK phosphorylation.
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Background
Mesenchymal stem cells (MSCs), which have been suc-
cessfully isolated from bone marrow, adipose tissue, 
umbilical cord blood, amniotic fluid, and peripheral 
blood, amongst other tissues, are multipotent cells that 
can differentiate into a variety of cell types, including 
osteoblasts, chondrocytes and adipocytes [1]. Recent 
studies have demonstrated that MSCs possessed immu-
nosuppressive and immunoregulatory activities [2]. 
Mesenchymal stem cells have been successfully used 
in the treatment of graft-versus-host disease and some 
autoimmune diseases such as insulin-dependent diabetes 
mellitus, experimental autoimmune encephalomyelitis 
and rheumatoid arthritis [3–6].
Human amnion mesenchymal cells (hAMCs) are iso-
lated from the amniotic membrane of human placenta. 
These cells possess stem cell characteristics and differen-
tiation potential [7]. Because hAMCs have a number of 
advantages including easily obtained, relatively exempt 
from ethical problem, do not express telomerase, and 
have a low risk of tumor formation, they might repre-
sent a new ideal MSCs resource for clinical application 
[8]. Recent studies have indicated that hAMCs also had 
immunomodulatory functions, including influencing T 
cell proliferation, and inhibiting dendritic cell (DC) dif-
ferentiation and maturation [9, 10]. However, whether 
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Inflammation plays an important role in the progression of 
many diseases, including cancer and autoimmune diseases 
[11, 12]. Macrophages are regarded as the key inflammatory 
cells associated with the pathologic process of inflammation 
[13]. Studies commonly investigate the response of THP-1 
cells, an immortalized human monocyte/macrophage cell 
line, to lipopolysaccharide (LPS) challenge as an appropri-
ate cell model system to study macrophage activation [14, 
15]. It was reported that LPS elicited the expression of mul-
tiple pro-inflammatory cytokines such as TNF-α and IL-1β 
in THP-1 cells, partly through the mitogen-activated protein 
kinase (MAPK)/NF-κB signaling pathway [16, 17]. There-
fore, this study investigated the effect of hAMCs on the pro-
duction of inflammatory cytokines and the regulation of the 
MAPK/NF-κB signaling pathway in LPS-stimulated THP-1 
cells, a classic inflammatory macrophage model.
Results
Morphological characterization of isolated hAMCs
Human amnion mesenchymal cells presented a colony-
like growth, with a mostly oval, spindle or polygonal in 
shape, and exhibiting a typical mesenchymal morphol-
ogy. To identify hAMCs further, we performed immu-
nofluorescence staining with antibodies to STRO-1 and 
vimentin, two mesenchymal stem cell specific markers. 
The results showed that these cells expressed STRO-1 
and vimentin in the cell cytoplasm (Fig. 1).
hAMCs co‑culture inhibit TNF‑α and IL‑1β production 
in LPS‑stimulated THP‑1 cells
To evaluate the effect of hAMCs on the expression of 
pro-inflammatory cytokines in LPS-stimulated THP-1 
cells, we measured the levels of TNF-α and IL-1β, 
two classic pro-inflammatory cytokines. As shown in 
Fig.  2, hAMCs secreted low concentrations of TNF-α 
(4.24  ±  0.89  pg/mL) and IL-1β (47.47  ±  23.14  pg/
mL) when treated with LPS for 24  h. Compared with 
the negative control group, TNF-α and IL-1β produc-
tion in THP-1 cells was remarkably increased after 
LPS stimulation (TNF-α  =  849.36  ±  13.94  pg/mL and 
IL-1β  =  655.98  ±  10.25  pg/mL). After co-culture with 
hAMCs for 24 h, TNF-α and IL-1β levels in LSP-stimu-
lated THP-1 cells was significantly decreased. The inhibi-
tory effect was concentration-dependent. When the ratio 
of hAMCs:THP-1 was 2:1, the TNF-α and IL-1β levels in 
supernatant were decreased to 39.76 ± 33.41 pg/mL and 
182.82 ± 3.68 pg/mL, respectively.
hAMCs co‑culture inhibit TNF‑α and IL‑1β mRNA 
expression in LPS‑stimulated THP‑1 cells
To detect changes in TNF-α and IL-1β levels in LPS-stim-
ulated THP-1 cells further, real-time PCR was used to 
measure cytokine mRNA expression. As shown in Fig. 3, 
the relative mRNA expression of TNF-α (0.007 ± 0.002) 
and IL-1β (4.408  ±  0.41) were low in hAMCs when 
treated with LPS for 24  h. Compared with the nega-
tive control group, the relative TNF-α and IL-1β mRNA 
expression in THP-1 cells was remarkably increased 
after stimulation with LPS, reaching 2.483 ±  0.323 and 
38.5 ± 2.323, respectively. After co-culture with hAMCs 
for 24  h, the relative TNF-α and IL-1β mRNA expres-
sion in LSP-stimulated THP-1 cells was significantly 
decreased. The inhibitory effect was concentration-
dependent. When the ratio of hAMCs: THP-1 was 2:1, 
Fig. 1 hAMCs express mesenchymal stem cell specific marker STRO-1 and vimentin. hAMCs were seeded onto 24-well plates and fixed by 4 % 
paraformaldehyde. After being blocked, cells were incubated with a mouse anti-human vimentin antibody or a mouse anti-human STRO-1 
antibody respectively overnight at 4 °C. After being incubated with fluorescence-conjugated secondary antibodies, the cells were observed under 
a fluorescent microscope. a Expression of mesenchymal marker STRO-1 in hAMCs. b Expression of mesenchymal marker vimentin in hAMCs. Magni-
fication: ×100
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the relative TNF-α and IL-1β mRNA expression in LPS-
stimulated THP-1 cells was decreased to 0.214 ±  0.032 
and 2.928 ± 0.955, respectively.
hAMCs supernatants inhibit TNF‑α and IL‑1β production 
in LPS‑stimulated THP‑1 cells
To further confirm the effect of hAMCs, we collected 
the supernatants of hAMCs and added them into LPS-
stimulated THP-1 cells, and the same results were found. 
As shown in Fig.  4, hAMCs supernatants also signifi-
cantly inhibited the production of pro-inflammatory 
cytokines TNF-α and IL-1β in LPS-stimulated THP-1 
cells (P < 0.01).
hAMCs have no inhibitory effect on THP‑1 cells viability
To investigate whether hAMCs supernatant or co-culture 
had inhibitory effect on THP-1 cells viability, we per-
form CCK-8 assay and cell counting. As shown in Fig. 5, 
20–100 % hAMCs supernatants did not display any cel-
lular toxicity against LPS-stimulated THP-1 cells over 
24 h. Further, co-culture of hAMCs with LPS-stimulated 
THP-1 cells for 24 h did not change the cell number of 
THP-1 cells. Before co-culture, 1  ×  106 THP-1 cells 
were added into the wells of a transwell plate. After co-
culture for 24  h, there was no significantly difference 
between THP-1+LPS group and THP-1+LPS+hAMCs 
Fig. 2 hAMCs co-culture inhibits LPS-induced TNF-α and IL-1β 
production in THP-1 cells. THP-1 cells were pre-treated with PMA 
to induce macrophage. Then, they were stimulated with 10 μg/mL 
LPS with or without different numbers of hAMCs (5 × 105, 1 × 106, 
2 × 106) in a 12-well transwell plate for 24 h at 37 °C. Expression levels 
of TNF-α (a) and IL-1β (b) in the culture supernatants were detected 
by ELISA. Data represent the mean ± S.D. of three independent 
experiments. **P < 0.01, vs. THP-1(+) LPS (−) group; #P < 0.05, 
##P < 0.01, vs. THP-1(+) LPS (+) group
Fig. 3 hAMCs co-culture inhibits the mRNA expression of TNF-α 
and IL-1β in LPS-stimulated THP-1 cells. THP-1 cells were pre-treated 
with PMA to induce macrophage. Then, they were stimulated with 
10 μg/mL LPS with or without different numbers of hAMCs (5 × 105, 
1 × 106, 2 × 106) in a 12-well transwell plate for 24 h at 37 °C. TNF-α 
mRNA (a) and IL-1β mRNA (b) expressions were determined by real 
time-PCR. GAPDH was used as a quantitative control. All experiments 
were performed three times. **P < 0.01, vs. THP-1(+) LPS (−) group; 
##P < 0.01, vs. THP-1(+) LPS (+) group
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(co-culture) group. The THP-1 cells numbers in two 
groups were 0.92 × 106 and 0.93 × 106, respectively.
hAMCs suppress the phosphorylation of ERK and JNK 
in LPS‑stimulated THP‑1 cells
To determine whether MAPK signaling pathways were 
involved in the regulatory effects of hAMCs on THP-1 
cells, we investigated the phosphorylation of two MAPK 
signaling molecules, ERK1/2 and JNK, and the activation 
of NF-κB. Western blot results showed that the levels of 
phosphorylated ERK1/2 and JNK, and NF-κB p65 were 
significantly up-regulated in THP-1 cells stimulated with 
LPS, whereas their levels were remarkably decreased in 
LPS-stimulated THP-1 cells after co-culture with hAMCs 
for 24  h. However, the total levels of ERK and JNK did 
not significantly change among these groups (Fig. 6).
Discussion
Recently, MSCs have received wide attention for their 
differentiation potential and immunomodulatory proper-
ties in regenerative medicine. Like MSCs from other tis-
sues, hAMCs also have immuno-inhibitory activities. A 
few groups have investigated hAMCs’ potential for treat-
ing immune-related diseases, such as multiple sclerosis, 
liver fibrosis, and spinal cord injury [18–20]. Although 
these studies demonstrate the anti-inflammatory effect 
of hAMCs, their mechanism of action is still poorly 
understood. In this study, we demonstrated that hAMCs 
reduced the production of TNF-α and IL-1β secreted by 
LPS-stimulated THP-1 cells, a model of inflammatory 
cell activation, which might be partly through suppress-
ing the MAPK/NF-κB signal pathway.
Inflammation is the first response to infection and 
injury and is critical to body defense, and restores and 
maintains homeostasis. However, excessive inflamma-
tion can cause inflammatory diseases [21]. Macrophages 
are regarded as a major component in the inflamma-
tory response [22, 23]. When stimulated by bacterial 
endotoxin, e.g. LPS, macrophages can secrete large 
amounts of inflammatory cytokines, such as TNF-α 
and IL-1β, and these inflammatory cytokines further 
Fig. 4 hAMCs supernatants inhibit LPS-induced TNF-α and IL-1β 
production in THP-1 cells. THP-1 cells were pre-treated with PMA to 
induce macrophage. Then, they were stimulated with LPS (10 μg/
mL) with or without hAMCs supernatants for 24 h at 37 °C. Expression 
levels of TNF-α (a) and IL-1β (b) in the culture supernatants of THP-1 
cells were detected by ELISA. Data represent the mean ± S.D. of three 
independent experiments. **P < 0.01, vs. THP-1 + LPS group
Fig. 5 hAMCs have no inhibitory effect on THP-1 cells viability. a 
Cells counting result. PMA-induced THP-1 cells were treated with 
LPS (10 μg/mL) with or without hAMCs in a 12-well transwell plate 
for 24 h at 37 °C. The THP-1 cells were then collected and counted. b 
CCK-8 assay result. THP-1 cells were firstly induced by PMA for 48 h. 
Then, different concentrations of hAMCs supernatants (0, 20, 40, 80, 
and 100 %) were added. 20 h later, 10 μL of CCK-8 reagent was added 
into each well and the cells were incubated for another 4 h. Finally, 
the absorbance of each well was measured at 450 nm. All experi-
ments were performed three times. Data are the mean ± S.D. of three 
independent experiments
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activate macrophages, causing a cascade of inflamma-
tory response [15]. In this study, we co-cultured hAMCs 
with LPS-stimulated THP-1 cells and found that hAMCs 
effectively inhibited pro-inflammatory cytokine produc-
tion in THP-1 cells. Moreover, treating LPS-stimulated 
THP-1 cells with hAMCs supernatants could also sup-
press TNF-α and IL-1β production in THP-1 cells. On 
the other hand, supernatants of LPS-stimulated THP-1 
cells could not promote hAMCs secreting TNF-α and 
IL-1β (data not shown). Further, hAMCs supernatants 
did not display any cellular toxicity against LPS-stim-
ulated THP-1 cells, which could exclude a nonspecific 
cytotoxicity as a possible explanation for the decreased 
cytokines output. Therefore, all these results further sup-
ported the anti-inflammatory activity of hAMCs.
Mitogen-activated protein kinases are a family of ser-
ine/threonine protein kinases, including ERKs and JNKs, 
which are regulated by a phosphorylation cascade, with 
a prototype of three protein kinases that sequentially 
phosphorylate one another [24]. Mitogen-activated pro-
tein kinases are responsible for most cellular responses 
to cytokines and are crucial for regulation of the pro-
duction of inflammatory mediators [25]. To investigate 
whether these pathways were involved in the molecular 
mechanisms of the suppressive effect of hAMCs on LPS-
stimulated THP-1 cells, we measured the levels of ERK 
and JNK phosphorylation. The levels of phosphoryla-
tion of ERK and JNK were up-regulated in THP-1 cells 
induced by LPS, but were significantly down-regulated 
after co-culture with hAMCs. These results indicated 
that hAMCs inhibited TNF-α and IL-1β production in 
macrophages by regulating MAPKs signaling pathways.
NF-κB is a major transcription factor that regulates 
both innate and adaptive immune responses. After being 
activated by a variety of stimuli, including LPS, it trans-
locates to the nucleus and binds its cognate DNA bind-
ing site to regulate the transcription of numerous genes, 
including cytokines, chemokines and stress-response 
proteins. NF-κB is a pivotal regulator of pro-inflam-
matory gene expression and is thought to be associated 
with some inflammatory diseases [26] because it is highly 
activated at sites of inflammation and the administra-
tion of NF-kB decoys is effective in an animal model of 
rheumatoid arthritis [27]. In the present experiment, 
co-culture with hAMCs remarkably down-regulated 
NF-κB level in LPS-stimulated THP-1 cells, which dem-
onstrated that the NF-κB signaling pathway was asso-
ciated with the inhibitory effect of hAMCs on THP-1 
cells. These results were also in accordance with previous 
reports. Co-culture of bone marrow-derived MSCs with 
macrophages down-regulated COX-2/PGE2 expression 
of macrophages by inhibiting the activation-associated 
phosphorylation of p38 MAPK and ERK [28]. Fang et al. 
also reported that adipose-derived MSCs transplanta-
tion suppressed inflammatory responses in rats with dia-
betic nephropathy induced by streptozotocin, partly by 
decreasing the expression of p-p38, p-ERK and p-JNK 
[29].
In conclusion, this study indicated that mediators 
secreted by hAMCs could inhibit the production of pro-
inflammatory cytokines in LPS-stimulated THP-1 cells, 
whether in co-culture condition or just with hAMCs 
supernatants. However, which mediators secreted by 
hAMCs participated in the immuno-inhibitory effect is 
still unknown. Previous studies reported that several sol-
uble factors including transforming growth factor (TGF-
β), hepatocyte growth factor (HGF), prostaglandin E2 
(PGE2), indoleamine 2, 3 dioxygenase (IDO) secreted by 
hAMCs were associated with immunomodulatory effects 
[30]. However, whether these factors are associated with 
hAMCs’ effects on LPS-stimulated THP-1 cells requires 
further study.
Conclusions
Taken together, this study demonstrated that hAMCs 
might prevent inflammatory responses by inhibiting the 
activation of NF-κB and the phosphorylation of MAPK 
Fig. 6 hAMCs inhibit the phosphorylation of MAPKs and activation 
of NF-κB in LPS-stimulated THP-1 cells. PMA-induced THP-1 cells were 
treated with LPS (10 μg/mL) with or without hAMCs (5 × 105, 1 × 106, 
2 × 106) in a 12-well transwell plate for 24 h at 37 °C. The cells were 
then collected and extracted. Western blot analysis was performed to 
detect p-ERK, total ERK, p-JNK, total JNK and p65. β-actin was used as 
an internal control
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pathways in LPS-stimulated THP-1 macrophages. These 
findings suggest that hAMCs may be useful for the treat-
ment of some inflammatory diseases.
Methods
Cell culture
THP-1, human monocyte-like cells, were purchased from 
Cell Culture Center of Chinese Academy of Medical Sci-
ences and cultured in RPMI1640 medium (Gibco BRL, 
Life Technologies, Grand Island, NY, USA) supplemented 
with 10 % fetal bovine serum (FBS), 100 U/mL penicillin, 
and 100 µg/mL streptomycin.
Isolation of human amnion mesenchymal cells
Human amnion mesenchymal cells were isolated from 
abandoned human placentas by trypsin and collagenase 
V according to our previous report with some modifica-
tions [8]. In brief, amnion layer was mechanically peeled 
off from the chorion layer and washed several times with 
Hanks’ balanced salt solution (HBSS) without calcium 
and magnesium to remove blood. Then, the amnion was 
digested with 0.25  % trypsin at 37  °C for 30  min. Fur-
ther, the amnion was cut into pieces of 1 cm2 and then 
digested with 0.1  % collagenase V (Sigma-Aldrich, St. 
Louis, MO, USA) at 37  °C for 30 min followed by cen-
trifugation (1500  rpm, 10  min) and thorough wash-
ing with phosphate buffer saline (PBS). Finally, isolated 
hAMCs were cultured in DMEM/F12 supplemented 
with 10 % FBS. hAMCs of no more than three passages 
were used for all experiments. All the correlated ethi-
cal issues concerning this study were approved by the 
corresponding institutional review board (IRB number: 
CJFH001035).
hAMCs—THP‑1 cell co‑culture
THP-1 cells were pre-treated for 48  h with 10  ng/mL 
phorbol 12-myristate 13-acetate (PMA) (Sigma-Aldrich, 
St. Louis, MO, USA) to induce differentiation to mac-
rophages [31]. After washing with PBS three times to 
remove PMA, they were stimulated with 10 μg/mL LPS 
(Sigma-Aldrich, St. Louis, MO, USA) with or without 
hAMCs in a 12-well transwell plate (0.4  μM pore size, 
Corning, Lowell, MA, USA) for 24  h at 37  °C. Experi-
ments were performed with different hAMCs num-
bers (5  ×  105, 1  ×  106, 2  ×  106) and with a constant 
number of THP-1 cells (1  ×  106), to obtain ratios of 
hAMCs:THP-1 of 0.5:1, 1:1, and 2:1. hAMCs were cul-
tured in the upper layer, while THP-1 cells were placed 
in the lower layer in RPMI1640 medium supplemented 
with 10 % FBS. After co-culture for 24 h, the superna-
tants were collected for ELISA assay, and the cells were 
collected and counted for real-time PCR and western 
blot analysis.
THP‑1 cells treatment
To further confirm the effect of hAMCs, we did a single-
culture experiment. THP-1 cells were pre-treated with 
PMA to induce macrophage. Then, they were stimulated 
with LPS (10  μg/mL) with or without hAMCs superna-
tants (100 %) for 24 h at 37 °C. Cells culture supernatants 
were collected and used for ELISA assay.
Immunofluorescence staining assay
Isolated hAMCs were seeded onto 24-well plates. After 
adherence, cells were washed three times with PBS 
and fixed by 4  % paraformaldehyde at room tempera-
ture for 30 min. Then, they were blocked with 1 % BSA 
for another 30  min. Subsequently, cells were incubated 
overnight at 4  °C with a mouse anti-human vimentin 
antibody (1:500 dilution, Chemicon, USA) or a mouse 
anti-human STRO-1 antibody (1:500 dilution, Chemicon, 
USA) respectively. After three washes, cells were incu-
bated with Alexa Fluor 488-conjugated goat anti-mouse 
IgG (Invitrogen, Life Technologies, Grand Island, NY, 
USA) or FITC-conjugated goat anti-mouse IgM (Sigma-
Aldrich, St. Louis, MO, USA) for 1 h. Finally, cells were 
observed under a fluorescent microscope.
CCK‑8 assay
THP-1 cells (1  ×  105 cells/mL) were seeded in 96-well 
plate and induced by PMA for 48  h in a 37  °C. Then, 
different concentrations of hAMCs supernatants were 
added. 20  h later, 10  μL of CCK-8 reagent was added 
into each well and the cells were incubated for another 
4 h. Finally, the absorbance of each well was measured at 
450 nm.
ELISA assay
For co-culture experiment, the supernatants were col-
lected after co-culture for 24 h. For single-culture experi-
ment, the supernatants were collected after hAMCs 
supernatant was added into the wells of LPS-stimulated 
THP-1 cells for 24  h. The concentration of IL-1β and 
TNF-α in the culture supernatant was measured by 
human IL-1β ELISA kit and human TNF-α ELISA kit 
(eBioscience, San Diego, CA, USA), according to the 
manufacturer’s instructions.
Real‑time PCR analysis
To quantify the mRNA expression of IL-1β and TNF-
α, real-time PCR amplification was conducted. Cells 
were collected and total RNA was isolated by Trizol 
reagent (Promega, Madison, WI, USA). The prim-
ers used were as follows: IL-1β, sense, 5′-TACA 
AG GAGAAGAAAGTAATGAC AA-3 ′ , ant i sense , 
5′-AGCTTGTTATTGATTTCTATCTTGT-3′; TNF-α, 
sense,5′-CTCCTCACCCACACCATCAGCCGCA-3′, 
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a n t i s e n s e , 5 ′ - ATA G AT G G G C T C ATA C C A G 
GGCTTG-3′; GAPDH, sense, 5′-CTCATGACCACAG 
TC C ATG C-3 ′ , ant i s ens e ,5 ′ -C AC AT TG G G G GT 
AGGAACAC-3′. GAPDH used as a quantitative control. 
The PCR conditions were 95  °C for 10 min, followed by 
40 cycles of 95 °C for 15 s and 60 °C for 60 s. All samples 
were measured in triplicate. Differences in gene expres-
sion were calculated using the 2−∆∆ct method.
Western blot analysis
After being induced by PMA and co-cultured with LPS 
and hAMCs for 24 h at 37 °C, THP-1 cells were collected 
to detect the expression of ERK, JNK, and NF-κB (p65). 
Whole-cell lysates were prepared using ice-cold cell lysis 
buffer. Protein concentration was determined using a 
BCA protein assay kit. Samples of cell lysates were sep-
arated by 10  % SDS-PAGE and then transferred onto 
polyvinylidene difluoride membranes and then immuno-
blotted with primary antibodies that recognized ERK 
(1:4000 dilution), JNK (1:2000 dilution), p-ERK (1:2000 
dilution), p-JNK (1:2000 dilution), GAPDH (1:5000 dilu-
tion) and p65 (1:200 dilution) (Cell Signaling Technology, 
Danvers, MA, USA). Next, peroxidase conjugated sec-
ondary antibodies and ECL detection systems were used 
according to routine methods. β-actin protein was used 
as an internal control.
Statistical analysis
All experiments were performed at least three times. 
Data were presented as mean  ±  S.D. Differences were 
evaluated using Statistical Package for Social Science 
11.0 (SPSS18.0). Statistical analysis was performed using 
analysis of variance (ANOVA) and comparison of means 
(Student’s t test). P  <  0.05 was considered statistically 
significant.
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